When you eat, GLP-1 signals your body to: Boosts insulin production to effectively manage blood glucose levels Slows digestion, enhancing feelings of fullness Helps regulate hunger signals, aiding adherence to calorie-controlled diets Due to these beneficial physiological effects, GLP-1 receptor agonists have become popular prescription medications for weight loss and metabolic health
Oral therapies and off patent semaglutide will affect pricing and access, competition intensifies in an increasingly segmented market, and innovation shifts the focus beyond weight loss alone towards comorbidity benefit, long-term maintenance and muscle preservation
After roughly 4 to 5 weeks of consistent dosing, your levels reach steady state: a stable plateau approximately 2.1 times higher than your very first dose, where the compound entering your system each week precisely replaces what was cleared
The landmark STEP 1 clinical trial showed that this mechanism, combined with lifestyle changes, led to significant weight loss
Over time, consistent weight loss can boost how well insulin works